Mike Choukour

Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low‐ and High‐Mineral‐Content Water on the Tablet in Healthy Adults

B. Wynne, M. Holton, A. Buchanan, 2017, Clinical pharmacology in drug development.

No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects

B. Wynne, N. Arya, T. Eley, 2016, BMC Infectious Diseases.

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

S. Piscitelli, S. Weller, B. Wynne, 2016, European Journal of Clinical Pharmacology.

The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects

B. Wynne, J. Humphreys, G. Bowers, 2016, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .